Abstract
Dr. Ssentongo delivered a podium presentation on a multicenter real-world study comparing dalbavancin with standard IV therapy for infective endocarditis in PWUD. The analysis used large EHR datasets and causal inference methods to assess outcomes and treatment completion, demonstrating dalbavancin as a practical strategy to improve care in this high-risk population.
| Original language | English (US) |
|---|---|
| State | Published - 2025 |
| Event | IDWeek 2025 - Georgia World Congress Center, Atlanta, United States Duration: Oct 19 2025 → Oct 22 2025 |
Conference
| Conference | IDWeek 2025 |
|---|---|
| Country/Territory | United States |
| City | Atlanta |
| Period | 10/19/25 → 10/22/25 |